Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 85Stomach Neoplasms 16Esophageal Neoplasms 14Neoplasms 10Cholangiocarcinoma 10Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 9Neoplasm Metastasis 8Adenocarcinoma Of Esophagus 8Esophageal Squamous Cell Carcinoma 7Endometrial Neoplasms 7Colorectal Neoplasms 7Pancreatic Adenocarcinoma 6Ovarian Neoplasms 6Lung Neoplasms 6Gallbladder Neoplasms 6Carcinoma, Ovarian Epithelial 6Adenocarcinoma 5Squamous Cell Carcinoma of Head and Neck 4Prostatic Neoplasms 4Melanoma 4Biliary Tract Neoplasms 4Urinary Bladder Neoplasms 3Sarcoma 3Liver Neoplasms 3Gastric Adenocarcinoma 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Anus Neoplasms 3Advanced Pancreatic Cancer 3

Interventions

camrelizumab 4Oxaliplatin 3apatinib 2S 1 (combination) 2Capecitabine 2XELOX 1Taxes 1Surgical Procedures, Operative 1Nivolumab 1Laparoscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Gastrectomy 1Conversion to Open Surgery 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Gastric Cancer × Taxes × Gastrointestinal × Clear all
NCT05524974 2022-09-01

Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes

Fujian Medical University

Phase 2 Not yet recruiting
203 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡